CPRX

Q: What is the price of Catalyst Pharmaceuticals (CPRX) today?

The price of Catalyst Pharmaceuticals (CPRX) today is R$ 108,07, with a variation of -2.97% compared to the last year. The price of Catalyst Pharmaceuticals (CPRX) started the year trading around R$ 113,12 and today it is at R$ 108,07. Follow the real-time price chart, the historical price of Catalyst Pharmaceuticals (CPRX), and stock data from Ibovespa and international markets.

Q: When does Catalyst Pharmaceuticals (CPRX) pay dividends?

Catalyst Pharmaceuticals (CPRX) did not distribute dividends in the last year.

Q: Catalyst Pharmaceuticals (CPRX) is it worth it?

Currently, Catalyst Pharmaceuticals (CPRX) is priced at R$ 108,07, with a P/E of 12,32%, representing a deviation of 19,34% from its historical average P/E. In the last year, the stock showed a variation of -2.97% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -2,97%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy shares of Catalyst Pharmaceuticals (CPRX)?

Investing in shares of Catalyst Pharmaceuticals (CPRX) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 shares of Catalyst Pharmaceuticals (CPRX) yield today?

The yield of Catalyst Pharmaceuticals (CPRX) was -4,91% in the last month, -2,97% in the last year and 500,60% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 shares of Catalyst Pharmaceuticals (CPRX) today, the total investment would be based on the current price of R$ 108,07.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 10.486,50In 5 years: R$ 64.909,72In 10 years: 59.366,57It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Catalyst Pharmaceuticals Inc.

Price

US$ 19,94

variation (12m)

-2,97%

p/l

12,32

p/vp

3,00

DIVIDEND YIELD

0,00%

quote CPRX

BVMF

CPRX

If you had invested

year ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of CPRX

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

-4,91%

3 months

-18,74%

1 year

-2,97%

2 years

40,03%

5 years

500,60%

10 years

449,31%

real profitability

profitability minus inflation.

1 month

-4,91%

3 months

-19,14%

1 year

-7,81%

2 years

27,64%

5 years

338,86%

10 years

225,65%

Indicators CPRX

check out the fundamentals of Catalyst Pharmaceuticals shares

P/L

12,32

Sector: -3,27 Industry: -3,27

P/SALES (PSR)

4,60

Sector: -3,77 Industry: -3,77

P/VP

3,00

Sector: 1,74 Industry: 1,74

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

21,47%

Sector: -63,50% Industry: -63,50%

ROE

24,38%

Sector: -67,23% Industry: -67,23%

ROIC

87,43%

Sector: -2.087,74% Industry: -2.087,74%

Net Margin

37,36%

Sector: -43,34% Industry: -43,34%

GROSS MARGIN

85,78%

Sector: 40,50% Industry: 40,50%

OPERATING MARGIN

43,59%

Sector: -43,21% Industry: -43,21%

P/EBITDA

9,14

Sector: -3,13 Industry: -3,13

P/EBIT

10,57

Sector: -3,41 Industry: -3,41

P/ASSETS

2,65

Sector: 1,29 Industry: 1,29

VPA

7,02

Sector: 1,80 Industry: 1,80

LPA

1,71

Sector: -2,09 Industry: -2,09

EQUITY / ASSETS

0,88

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

36,22%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

22,72%

Sector: - Industry: -

FAIR PRICE OF Catalyst Pharmaceuticals ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 19,94

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-17,58%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

CPRX indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	Net Margin
JNJ	19,04	5,50	28,88%	2,80%	US$ 431,37 B	25,00%
PFE	13,45	1,62	12,08%	6,68%	US$ 144,63 B	16,84%
ABBV	79,66	228,58	286,94%	3,38%	US$ 334,19 B	7,31%
NVO	15,51	9,75	62,86%	2,83%	US$ 253,39 B	35,63%
MRK	13,05	4,36	33,44%	3,75%	US$ 214,13 B	25,79%
BMY	19,31	5,58	28,87%	5,13%	US$ 97,52 B	10,58%
GILD	22,64	7,29	32,21%	2,72%	US$ 142,89 B	21,87%
AZN	30,26	5,60	18,51%	1,91%	US$ 251,01 B	14,68%
ZTS	26,68	14,00	52,48%	1,19%	US$ 69,70 B	27,83%
HALO	15,59	26,12	167,47%	0,00%	US$ 8,69 B	47,28%
REGN	13,88	2,07	14,89%	0,30%	US$ 61,90 B	31,37%
AMGN	23,87	21,27	89,11%	3,15%	US$ 158,02 B	18,96%
VRTX	27,92	5,91	21,18%	0,00%	US$ 101,55 B	31,86%
ADMA	20,53	10,77	52,45%	0,00%	US$ 4,29 B	44,06%
MCK	27,24	-99,86	-366,63%	0,41%	US$ 86,18 B	0,84%
BIIB	13,38	1,16	8,68%	0,00%	US$ 20,48 B	15,31%
CAH	22,58	-13,38	-59,26%	1,37%	US$ 35,25 B	0,70%

comparison of CPRX with indexes

If you had invested (change) 2 years a year ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history CPRX dividend history

Current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Inc.

Average user rating I10

4.0 (2 people)

Estados Unidos

19 years

Foundation: 2006

2006

Year of debut on the stock exchange - 19 years

74

Employees

The Company Catalyst Pharmaceuticals Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 2,57 Billions, having a net worth of $ 856,03 Milhões.

With a total of 74 employees, the company is listed in the sector of Cuidados de saúde and categorized in industry of Biotecnologia.

In the last 12 months the Company had a revenue of $ 558,49 Milhões, which generated a profit in the amount of $ 208,67 Milhões.

As for its main indicators, the Company has a P/E ratio of 12,32, a P/B ratio of 3,00 and in the last 12 months the Company did not pay dividends.

The Company is traded through the ticker CPRX.

Market value

US$ 2,57 Billions

Net worth

US$ 856,03 Milhões

US$ 856.030.000,00

Assets

US$ 971,91 Milhões

US$ 971.910.000,00

Total Number of Shares

122,00 Milhões

122.000.000

Average Daily Trading Volume

US$ 1,40 Million

US$ 1.400.879,40

Sector

Cuidados de saúde

Industry

Biotecnologia

CPRX

CPRX revenue and profits

CPRX results

DRAG THE FRAME TO SEE MORE DATA

CPRX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 680,52 24,27% (12M)

P/L

27,24

0,41%

ROE

-366,63%

P/VP

-99,86

CAH - Cardinal Health

US$ 147,49 36,56% (12M)

P/L

22,58

1,37%

ROE

-59,26%

P/VP

-13,38

JNJ - Johnson & Johnson

US$ 176,49 12,66% (12M)

P/L

19,04

2,80%

ROE

28,88%

P/VP

5,50

MRK - Merck & Co.

US$ 84,99 --23,85% (12M)

P/L

13,05

3,75%

ROE

33,44%

P/VP

4,36

PFE - Pfizer

US$ 24,92 --5,92% (12M)

P/L

13,45

6,68%

ROE

12,08%

P/VP

1,62

AZN - AstraZeneca

US$ 80,05 --5,68% (12M)

P/L

30,26

1,91%

ROE

18,51%

P/VP

5,60

ABBV - AbbVie

US$ 208,36 10,15% (12M)

P/L

79,66

3,38%

ROE

286,94%

P/VP

228,58

BFRA - Biofrontera

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 680,52 24,27% (12 M)

P/L

27,24

0,41%

ROE

-366,63%

P/VP

-99,86

CAH - Cardinal Health

US$ 147,49 36,56% (12 M)

P/L

22,58

1,37%

ROE

-59,26%

P/VP

-13,38

JNJ - Johnson & Johnson

US$ 176,49 12,66% (12 M)

P/L

19,04

2,80%

ROE

28,88%

P/VP

5,50

MRK - Merck & Co.

US$ 84,99 --23,85% (12 M)

P/L

13,05

3,75%

ROE

33,44%

P/VP

4,36

PFE - Pfizer

US$ 24,92 --5,92% (12 M)

P/L

13,45

6,68%

ROE

12,08%

P/VP

1,62

AZN - AstraZeneca

US$ 80,05 --5,68% (12 M)

P/L

30,26

1,91%

ROE

18,51%

P/VP

5,60

ABBV - AbbVie

US$ 208,36 10,15% (12 M)

P/L

79,66

3,38%

ROE

286,94%

P/VP

228,58

Common Questions

What is the price of Catalyst Pharmaceuticals (CPRX) today?

The price of Catalyst Pharmaceuticals (CPRX) today is R$ 108,07, with a variation of -2.97% compared to the last year. The price of Catalyst Pharmaceuticals (CPRX) started the year trading around R$ 113,12 and today it is at R$ 108,07. Follow the real-time price chart, the historical price of Catalyst Pharmaceuticals (CPRX), and stock data from Ibovespa and international markets.

When does Catalyst Pharmaceuticals (CPRX) pay dividends?

Catalyst Pharmaceuticals (CPRX) did not distribute dividends in the last year.

Catalyst Pharmaceuticals (CPRX) is it worth it?

Currently, Catalyst Pharmaceuticals (CPRX) is priced at R$ 108,07, with a P/E of 12,32%, representing a deviation of 19,34% from its historical average P/E. In the last year, the stock showed a variation of -2.97% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -2,97%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy shares of Catalyst Pharmaceuticals (CPRX)?

Investing in shares of Catalyst Pharmaceuticals (CPRX) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 shares of Catalyst Pharmaceuticals (CPRX) yield today?

The yield of Catalyst Pharmaceuticals (CPRX) was -4,91% in the last month, -2,97% in the last year and 500,60% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 shares of Catalyst Pharmaceuticals (CPRX) today, the total investment would be based on the current price of R$ 108,07.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 10.486,50
In 5 years: R$ 64.909,72
In 10 years: 59.366,57

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

CPRX

Catalyst Pharmaceuticals Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of CPRX

check out the fundamentals of Catalyst Pharmaceuticals shares

P/L

P/SALES (PSR)

P/VP

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

Net Margin

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSETS

VPA

LPA

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years a year ago, today you would have

Current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Inc.

Estados Unidos

19 years

2006

74

PROFIT X PRICE CPRX

CPRX results

CPRX cash flow

evolution of assets - CPRX

CPRX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

AZN - AstraZeneca

ABBV - AbbVie

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

AZN - AstraZeneca

ABBV - AbbVie

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80